SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-070189
Filing Date
2023-06-12
Accepted
2023-06-12 09:41:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 DFAN14A tm2318441d1_dfan14a.htm DFAN14A 40749
2 GRAPHIC tm2318441d1_dfan14aimg001.jpg GRAPHIC 27168
3 GRAPHIC tm2318441d1_dfan14aimg002.jpg GRAPHIC 3275
  Complete submission text file 0001104659-23-070189.txt   84714
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: DFAN14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-37345 | Film No.: 231007260
SIC: 2834 Pharmaceutical Preparations